BACKGROUND:About one-third of the cervical cancer cases in Sweden occur in women over the age of 60. The primary aim of this study was to analyze the incidence of HPV, and HPV related dysplasia, in elderly women who had an HPV negative test at the age of 60 years or older. METHODS:From October 2004 to June 2019, 1784 women aged 60-90 years were sampled for an HPV test when attending an outpatient gynecology clinic. Of these women, 827 HPV-negative women had two or more HPV tests at intervals of three months to eleven years (mean 3.2 years). The women with positive results had a repeat HPV test and cytology after 2.5 months on average. Those with a positive repeat HPV test were examined by colposcopy and biopsy. FINDINGS:The overall prevalen...
Background: Large-scale data on type-specific HPV prevalences and disease burden are needed to monit...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
Background: About one-third of the cervical cancer cases in Sweden occur in women over the age of 60...
Introduction: In Sweden, where screening ends at the age of 60, about 30% of the cervical cancer cas...
In Sweden, where screening ends at the age of 60, about 30% of the cervical cancer cases occur in wo...
Purpose: Cervical cancer prevention for older women can be challenging since there are no specific g...
Background About 30% of the cervical cancer cases in Sweden occur in women older than 60. The primar...
BackgroundAbout 30% of the cervical cancer cases in Sweden occur in women older than 60. The primary...
AimMany cervical cancers occurs among women over 65 and prevalence of HPV genotypes in this age coho...
IntroductionDanish women exit cervical cancer screening at age 65 years, but 23% of cervical cancer ...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
Introduction: The screening program for cervical cancer in Sweden recommends the use of primary huma...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
Background: Large-scale data on type-specific HPV prevalences and disease burden are needed to monit...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
Background: About one-third of the cervical cancer cases in Sweden occur in women over the age of 60...
Introduction: In Sweden, where screening ends at the age of 60, about 30% of the cervical cancer cas...
In Sweden, where screening ends at the age of 60, about 30% of the cervical cancer cases occur in wo...
Purpose: Cervical cancer prevention for older women can be challenging since there are no specific g...
Background About 30% of the cervical cancer cases in Sweden occur in women older than 60. The primar...
BackgroundAbout 30% of the cervical cancer cases in Sweden occur in women older than 60. The primary...
AimMany cervical cancers occurs among women over 65 and prevalence of HPV genotypes in this age coho...
IntroductionDanish women exit cervical cancer screening at age 65 years, but 23% of cervical cancer ...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
Introduction: The screening program for cervical cancer in Sweden recommends the use of primary huma...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
Background: Large-scale data on type-specific HPV prevalences and disease burden are needed to monit...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...
BackgroundHigh-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical ca...